Posted in | News | LEDs | Lighting

Philips Enters LED Patent Cross-License Agreement with Cree

Philips and Cree have signed a patent cross-license deal to boost its market growth in the LED lighting sector. Both the companies have broad patent portfolios in optoelectronics.

The new patent agreement signed by the companies will cover their patents in various fields such as white LEDs and phosphors, LED luminaires and lamps, and blue LED chip technology. The agreement will also cover patents associated with the Philips’ LED Luminaire Licensing Program, and LED backlighting of LCDs.

The Chairman of Cree, Chuck Swoboda, stated that the agreement indicates the commitment of both the companies to develop the LED lighting market and their respect for the importance and value of the intellectual property laws.

The CEO of Philips Lighting, Rudy Provoost, said that both the companies have made a significant investment in LED lighting solutions. The company is pleased that Cree will be joining the LED Luminaire Licensing Program, he added.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    WOLFSPEED, INC.. (2019, March 19). Philips Enters LED Patent Cross-License Agreement with Cree. AZoOptics. Retrieved on November 07, 2024 from https://www.azooptics.com/News.aspx?newsID=10032.

  • MLA

    WOLFSPEED, INC.. "Philips Enters LED Patent Cross-License Agreement with Cree". AZoOptics. 07 November 2024. <https://www.azooptics.com/News.aspx?newsID=10032>.

  • Chicago

    WOLFSPEED, INC.. "Philips Enters LED Patent Cross-License Agreement with Cree". AZoOptics. https://www.azooptics.com/News.aspx?newsID=10032. (accessed November 07, 2024).

  • Harvard

    WOLFSPEED, INC.. 2019. Philips Enters LED Patent Cross-License Agreement with Cree. AZoOptics, viewed 07 November 2024, https://www.azooptics.com/News.aspx?newsID=10032.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.